Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4(5):389–98.

Article  PubMed  Google Scholar 

Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851–61.

Article  PubMed  Google Scholar 

Morita S, NetoDde S, Morita FH, Morita NK, Lobo SM. Prevalence of non-alcoholic fatty liver disease and steatohepatitis risk factors in patients undergoing bariatric surgery. Obes Surg. 2015;25(12):2335–43.

Article  PubMed  Google Scholar 

Ekstedt M, Hagstrom H, Nasr P, Fredrikson M, Stal P, Kechagias S, Hultcrantz R. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2015;61(5):1547–54.

Article  CAS  PubMed  Google Scholar 

Orci LA, Sanduzzi-Zamparelli M, Caballol B, Sapena V, Colucci N, Torres F, et al. Incidence of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review, meta-analysis, and meta-regression. Clin Gastroenterol Hepatol. 2022;20(2):283-92.e10.

Article  PubMed  Google Scholar 

Bedossa P, Poitou C, Veyrie N, Bouillot JL, Basdevant A, Paradis V, et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology. 2012;56(5):1751–9.

Article  PubMed  Google Scholar 

Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–21.

Article  PubMed  Google Scholar 

Shiha G, Sarin SK, Ibrahim AE, Omata M, Kumar A, Lesmana LA, et al. Liver fibrosis: consensus recommendations of the Asian Pacific Association for the study of the Liver (APASL). Hepatol Int. 2009;3(2):323–33.

Article  PubMed  Google Scholar 

Castera L, Vilgrain V, Angulo P. Noninvasive evaluation of NAFLD. Nat Rev Gastroenterol Hepatol. 2013;10(11):666–75.

Article  CAS  PubMed  Google Scholar 

Nassif AT, Nagano TA, Okayama S, Nassif LS, BrancoFilho A, Sampaio NJ. Performance of the bard scoring system in bariatric surgery patients with nonalcoholic fatty liver disease. Obes Surg. 2017;27(2):394–8.

Article  PubMed  Google Scholar 

Simo KA, McKillop IH, McMillan MT, Ahrens WA, Walters AL, Thompson KJ, et al. Does a calculated “NAFLD fibrosis score” reliably negate the need for liver biopsy in patients undergoing bariatric surgery? Obes Surg. 2014;24(1):15–21.

Article  PubMed  Google Scholar 

Ooi GJ, Burton PR, Doyle L, Wentworth JM, Bhathal PS, Sikaris K, et al. Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese. Obes Surg. 2017;27(1):115–25.

Article  PubMed  Google Scholar 

Alqahtani SA, Golabi P, Paik JM, Lam B, Moazez AH, Elariny HA, et al. Performance of noninvasive liver fibrosis tests in morbidly obese patients with nonalcoholic fatty liver disease. Obes Surg. 2021;31(5):2002–10.

Article  PubMed  PubMed Central  Google Scholar 

Lefebvre T, Wartelle-Bladou C, Wong P, Sebastiani G, Giard JM, Castel H, et al. Prospective comparison of transient, point shear wave, and magnetic resonance elastography for staging liver fibrosis. Eur Radiol. 2019;29(12):6477–88.

Article  PubMed  Google Scholar 

Selvaraj EA, Mózes FE, Jayaswal ANA, Zafarmand MH, Vali Y, Lee JA, et al. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis. J Hepatol. 2021;75(4):770–85.

Article  PubMed  Google Scholar 

Sarker IH. Machine learning: Algorithms, real-world applications and research directions. SN Computer Science. 2021;2(3):160.

Article  PubMed  PubMed Central  Google Scholar 

Su TH, Wu CH, Kao JH. Artificial intelligence in precision medicine in hepatology. J Gastroenterol Hepatol. 2021;36(3):569–80.

Article  PubMed  Google Scholar 

Wu HC, Hsieh YR, Wang W, Chang CW, Chang IW, Chen CL, et al. Potential Hepatic Lipid Markers Associated with Nonalcoholic Steatohepatitis and Fibrosis in Morbid Obesity Patients. J Clin Med. 2023;12(11):3730.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hung CH, Lu SN, Wang JH, Lee CM, Chen TM, Tung HD, et al. Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis. J Gastroenterol. 2003;38(2):153–7.

Article  PubMed  Google Scholar 

Kao WY, Chang IW, Chen CL, Su CW, Fang SU, Tang JH, et al. Fibroscan-Based Score to Predict Significant Liver Fibrosis in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease. Obes Surg. 2020;30(4):1249–57.

Article  PubMed  Google Scholar 

Kao WY, Lin YF, Chang IW, Chen CL, Tang JH, Chang CC, et al. Interleukin-2 receptor alpha as a biomarker for nonalcoholic fatty liver disease diagnosis. J Chin Med Assoc. 2021;84(3):261–6.

Article  CAS  PubMed  Google Scholar 

Rafało M. Cross validation methods: Analysis based on diagnostics of thyroid cancer metastasis. ICT Express. 2022;8(2):183–8.

Article  Google Scholar 

An Q, Rahman S, Zhou J, Kang JJ. A Comprehensive Review on Machine Learning in Healthcare Industry: Classification, Restrictions, Opportunities and Challenges. Sensors (Basel). 2023Apr 22;23(9):4178. https://doi.org/10.3390/s23094178.

Article  PubMed  Google Scholar 

Peterson L. K-nearest neighbor. Scholarpedia. 2009;4:1883.

Article  Google Scholar 

Chen T, Guestrin C. XGBoost: A Scalable Tree Boosting System. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining; San Francisco, California, USA: Association for Computing Machinery; 2016. p. 785–94.

Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–91.

Article  PubMed  Google Scholar 

Carpenter J, Bithell J. Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat Med. 2000;19(9):1141–64.

Article  CAS  PubMed  Google Scholar 

Xia J, Broadhurst D, Wilson M, Wishart D. Translational biomarker discovery in clinical metabolomics: An introductory tutorial. Metabolomics: Off J Metab Soc. 2013;9:280–99.

Article  CAS  Google Scholar 

Good P. Analyzing the large number of variables in biomedical and satellite imagery. 2011. https://doi.org/10.1002/9780470937273.

DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–45.

Article  CAS  PubMed  Google Scholar 

EASL-EASD-EASO. Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388–402.

Sarvestany SS, Kwong JC, Azhie A, Dong V, Cerocchi O, Ali AF, et al. Development and validation of an ensemble machine learning framework for detection of all-cause advanced hepatic fibrosis: a retrospective cohort study. The Lancet Digital Health. 2022;4(3):e188–99.

Article  CAS  PubMed  Google Scholar 

Blanes-Vidal V, Lindvig KP, Thiele M, Nadimi ES, Krag A. Artificial intelligence outperforms standard blood-based scores in identifying liver fibrosis patients in primary care. Sci Rep. 2022;12(1):2914.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Musolf AM, Holzinger ER, Malley JD, Bailey-Wilson JE. What makes a good prediction? Feature importance and beginning to open the black box of machine learning in genetics. Hum Genet. 2022;141(9):1515–28.

Article  PubMed  Google Scholar 

Mueller S, Sandrin L. Liver stiffness: a novel parameter for the diagnosis of liver disease. Hepat Med. 2010;2:49–67.

Article  PubMed  PubMed Central  Google Scholar 

Myers RP, Pomier-Layrargues G, Kirsch R, Pollett A, Duarte-Rojo A, Wong D, et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology. 2012;55(1):199–208.